Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
(13-15 November) AHA 2021
Meet with us for compelling content and renewed connections at AHA Scientific Sessions 2021. In-person Event in Boston, Massachusetts Virtual Experience, Saturday, November 13-15.
Abstract presentations are a key component of AHA Scientific Sessions. Abstract presenters have the option to present in person in Boston or as a part of the virtual experience.
The incentive to disseminate the latest cardiovascular and stroke science to colleagues around the world has never been greater.
Clinicians and Scientists thrive on collaboration and sharing their study findings. Present your innovative research to a global audience at Scientific Sessions, the world’s premier cardiovascular conference.
We know your work is vital to saving lives. Share it with fellow researchers, clinicians, and scientists.
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders